Rakuten Securities, Inc. Sarepta Therapeutics, Inc. Transaction History
Rakuten Securities, Inc.
- $254 Billion
- Q4 2024
A detailed history of Rakuten Securities, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Rakuten Securities, Inc. holds 57 shares of SRPT stock, worth $5,539. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57
Previous 40
42.5%
Holding current value
$5,539
Previous $5 Million
38.73%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SRPT
# of Institutions
535Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$883 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$845 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$421 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$396 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $8.51B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...